Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen K Gruschkus

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 1, 2014
Adverse drug events among patients receiving postsurgical opioids in a large health system: risk factors and outcomesHarold S Minkowitz, Stephen K Gruschkus, Manan Shah, et al.
Pharmacotherapy|April 5, 2013
Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomesE Richard Kessler, Manan Shah, Stephen K Gruschkus, et al.
Journal of the American Geriatrics Society|September 16, 2010
Comparative effectiveness of white blood cell growth factors on neutropenia, infection, and survival in older people with non-Hodgkin's lymphoma treated with chemotherapyStephen K Gruschkus, David Lairson, J Kay Dunn, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2011
Cost-effectiveness of white blood cell growth factor use among a large nationwide cohort of elderly non-Hodgkin's lymphoma patients treated with chemotherapyStephen K Gruschkus, David Lairson, J Kay Dunn, et al.
Cancer|July 29, 2010
Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphomaStephen K Gruschkus, David Lairson, J Kay Dunn, et al.
Journal of Managed Care & Specialty Pharmacy|August 29, 2014
Development and validation of a risk score to identify patients at high risk for opioid-related adverse drug eventsHarold S Minkowitz, Richard Scranton, Stephen K Gruschkus, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2013
Cost effectiveness of first-line pemetrexed plus platinum compared with other regimens in the treatment of patients with nonsquamous non-small cell lung cancer in the US outpatient settingManan Shah, Katherine B Winfree, Patrick Peterson, et al.
Psychiatric Services (Washington, D.C.)|March 17, 2026
Evaluation of an Integrated Behavioral Health Care Clinical Service Line for Depression: A Quality Improvement InitiativeSabrina K Segal, Charles L Weber, Stephen K Gruschkus, et al.
Polish Journal of Radiology|May 24, 2024
Assessing the effectiveness of MRI, <sup>18</sup>F-fluciclovine PET, SUV<sub>max</sub>, and PSA in detecting local recurrence of prostate cancer after prostatectomyMayur K Virarkar, Stephen K Gruschkus, Gregory C Ravizzini, et al.
Aerospace Medicine and Human Performance|July 20, 2017
Clinical Herpes Zoster in Antarctica as a Model for SpaceflightDavid P Reyes, Alaina A Brinley, Rebecca S Blue, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 1, 2014
Adverse drug events among patients receiving postsurgical opioids in a large health system: risk factors and outcomesHarold S Minkowitz, Stephen K Gruschkus, Manan Shah, et al.
Pharmacotherapy|April 5, 2013
Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomesE Richard Kessler, Manan Shah, Stephen K Gruschkus, et al.
Journal of the American Geriatrics Society|September 16, 2010
Comparative effectiveness of white blood cell growth factors on neutropenia, infection, and survival in older people with non-Hodgkin's lymphoma treated with chemotherapyStephen K Gruschkus, David Lairson, J Kay Dunn, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2011
Cost-effectiveness of white blood cell growth factor use among a large nationwide cohort of elderly non-Hodgkin's lymphoma patients treated with chemotherapyStephen K Gruschkus, David Lairson, J Kay Dunn, et al.
Cancer|July 29, 2010
Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphomaStephen K Gruschkus, David Lairson, J Kay Dunn, et al.
Journal of Managed Care & Specialty Pharmacy|August 29, 2014
Development and validation of a risk score to identify patients at high risk for opioid-related adverse drug eventsHarold S Minkowitz, Richard Scranton, Stephen K Gruschkus, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2013
Cost effectiveness of first-line pemetrexed plus platinum compared with other regimens in the treatment of patients with nonsquamous non-small cell lung cancer in the US outpatient settingManan Shah, Katherine B Winfree, Patrick Peterson, et al.
Psychiatric Services (Washington, D.C.)|March 17, 2026
Evaluation of an Integrated Behavioral Health Care Clinical Service Line for Depression: A Quality Improvement InitiativeSabrina K Segal, Charles L Weber, Stephen K Gruschkus, et al.
Polish Journal of Radiology|May 24, 2024
Assessing the effectiveness of MRI, <sup>18</sup>F-fluciclovine PET, SUV<sub>max</sub>, and PSA in detecting local recurrence of prostate cancer after prostatectomyMayur K Virarkar, Stephen K Gruschkus, Gregory C Ravizzini, et al.
Aerospace Medicine and Human Performance|July 20, 2017
Clinical Herpes Zoster in Antarctica as a Model for SpaceflightDavid P Reyes, Alaina A Brinley, Rebecca S Blue, et al.
Pageof 3